Skip to content
Home/Companies/TMT/Nereus Pharmaceuticals
NP

Nereus Pharmaceuticals

TMT·US·Exited 2012

Nereus Pharmaceuticals is a TMT company, headquartered in United States.

Entry
–
Hold
–
Exit
2012
Est. EV
–

Who owns Nereus Pharmaceuticals?

Nereus Pharmaceuticals was owned by Gimv, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

Gimv
Investor
Gimv
Fund attribution unclassified.

Key facts

HQUnited States
SectorTMT
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2012

More from Gimv Portfolio

Other portfolio companies in the same fund.

Ablynx
Exited 2013
TMTBelgium
Acceo
Active
TMTBelgium
Acertys Group
Exited 2015
TMTBelgium
to
ActoGeniX
Exited 2015
TMTBelgium
to
AgroBiothers
Active
TMTBelgium
Almaviva
Exited 2017
TMTBelgium
to

More PE-backed in TMT

Comparable tmt deals from other GPs.

1500h
Active
QUANTONATION VENTURESFrance
24ORE
Active
FemuQui VenturesFrance
2Checkout (Avangate)
Exited
Francisco PartnersUS
3878 Best
Active
QUANTONATION VENTURES
3Bee
Active
AgFunderUS
3ma group
Active
Isatis CapitalFrance
Data refreshed weekly · Sourced from public filings